(a) Trial design: participants fixated on the centre, heard a cue for the condition (Performance/Random/10 p/0 p), waited a delay (1400/1500/1600 ms) and then looked towards to the circle that lit …
The mean measures for the four conditions (Performance, Random, Guaranteed 10p, Guaranteed 0p) for each variable, with individual data points. The difference between Performance and Random shows the …
Source individual data for all saccade measures for PD ON, OFF and HC.
The figures can be constructed using the DrawSaccadeFigures.m Matlab file available from the ContingentAnalysis GitHub repo (see Data and Code Availability section of manuscript).
The top row shows the effects of contingent rewards (i.e. measures in Performance conditions minus the Random condition), and the bottom row shows effects of guaranteed rewards (10 p condition minus …
Source individual data for saccade velocity and acceleration for PD ON, OFF and HC.
The figures can be constructed using the DrawVelFigures.m Matlab file available from the ContingentAnalysis GitHub repo (see Data and Code Availability section of manuscript).
Individual data showing each participant’s mean effects of contingent (Performance – Random) and guaranteed (10 p – 0 p) rewards on velocity and acceleration during saccades.
Each image shows the effect of reward on mean correlation coefficient between the eye-position at one (interpolated) time-point within a saccade with all other time-points in that same saccade. As …
Source individual data for autocorrelation coefficients for PD ON, OFF and HC.
The figures can be constructed using the DrawAutocorrelFigures.m Matlab file available from the ContingentAnalysis GitHub repo (see Data and Code Availability section of manuscript).
Individual participants’ autocorrelation matrices.
Individual data showing each participant’s mean effects of contingent (Performance – Random) and guaranteed (10 p – 0 p) rewards on (Fisher transformed) eye-position autocorrelation matrices. Blank matrices for PD patients reflect excluded participants.
Each plot shows the effect of motivation (top row = contingent, bottom row = guaranteed) on the signed log covariance matrix, for PD ON, OFF, HC, and the difference between PD ON and OFF. Green …
Scatter plots of the effect of contingent and guaranteed rewards (i.e. contingent effect = Performance minus Random trials, guaranteed effect = guaranteed 10 p minus guaranteed 0 p trials) on peak …
Source individual data for velocity residual correlations for PD ON, OFF and HC.
The figures can be constructed using the DrawCorrelFigures.m Matlab file available from the ContingentAnalysis GitHub repo (see Data and Code Availability section of manuscript).
The effects of contingent (top) and guaranteed rewards (bottom) on pupil dilatation in the different conditions up to 1400 ms after the reward cue. Pupil dilatation is baselined to the time of cue …
Source individual data for pupil dilatation for PD ON, OFF and HC.
The figures can be constructed using the DrawPupilFigures.m Matlab file available from the ContingentAnalysis GitHub repo (see Data and Code Availability section of manuscript).
Scatter plots of the effect of contingent and guaranteed rewards (i.e. contingent effect = Performance minus Random trials, guaranteed effect = guaranteed 10 p minus guaranteed 0 p trials) on pupil …
Individual participants’ mean pupil dilatation traces for each condition, showing the effects of contingent (Performance – Random) and guaranteed (10 p – 0 p) rewards.
We propose that dopamine (in PD patients) increases contingent motivation by acting on the caudate nucleus, which disinhibits the superior colliculus (via the basal ganglia output nuclei) and …
Standard deviations are given in parentheses. **=p < 0.01 (independent samples t-test). ACE = Addenbrooke’s Cognitive Exam, AMI = Apathy and Motivation Index, HADS = Hospital Anxiety and Depression …
PD | HC | |
---|---|---|
Number | 26 | 29 |
Age | 67.69 (1.48) | 67.41 (6.83) |
Gender (M:F) | 19:7 | 15:14 |
ACE | 93.04 (6.47) | 97.10 (2.11)** |
AMI | 1.48 (0.56) | 1.28 (0.47) |
HADS-A | 2.92 (2.92) | 4.29 (2.79) |
HADS-D | 2.50 (1.84) | 2.17 (1.83) |
BDI-II | 4.90 (3.60) | 5.84 (3.78) |
FSS | 3.19 (1.21) | 3.02 (1.03) |
UPDRS-III ON | 26.69 (9.20) | N/A |
UPDRS-III OFF | 35.04 (11.17) | N/A |
LED | 490.23 (324.28) | N/A |
# on agonists | 6 | N/A |
Three-way (motivation*contingency*drug) repeated-measures ANOVA on each behavioural measure, for the PD patients ON and OFF medication. An effect of contingency means the guaranteed conditions (10 …
Measure | Effect | F (1, 200) | p | |
---|---|---|---|---|
Peak Velocity Residuals | Motivation | 9.7704 | *.0020 | .0466 |
Contingency | 0.0194 | . 8895 | . 0001 | |
Drug | 0.0004 | . 9850 | . 0000 | |
Motivation * Contingency | 0.0051 | . 9429 | . 0000 | |
Motivation * Drug | 0.2626 | . 6089 | . 0013 | |
Contingency * Drug | 11.1072 | **.0010 | . 0526 | |
Contingency * Motivation * Drug | 9.5190 | **.0023 | . 0454 | |
Amplitude | Motivation | 3.5577 | . 0607 | . 0175 |
Contingency | 1.2284 | . 2690 | . 0061 | |
Drug | 0.0000 | . 9984 | . 0000 | |
Motivation * Contingency | 0.5545 | . 4573 | . 0028 | |
Motivation * Drug | 0.2278 | . 6337 | . 0011 | |
Contingency * Drug | 1.7763 | . 1841 | . 0088 | |
Contingency * Motivation * Drug | 0.0287 | . 8655 | . 0001 | |
Saccadic RT | Motivation | 3.4333 | . 0654 | . 0169 |
Contingency | 4.2922 | *.0396 | . 0210 | |
Drug | 0.3560 | . 5514 | . 0018 | |
Motivation * Contingency | 0.3663 | . 5457 | . 0018 | |
Motivation * Drug | 0.0694 | . 7925 | . 0003 | |
Contingency * Drug | 0.6246 | . 4303 | . 0031 | |
Contingency * Motivation * Drug | 0.0185 | . 8920 | . 0001 | |
Endpoint Variability | Motivation | 2.6780 | . 1033 | . 0132 |
Contingency | 3.6181 | . 0586 | . 0178 | |
Drug | 1.0095 | . 3162 | . 0050 | |
Motivation * Contingency | 3.9524 | *.0482 | . 0194 | |
Motivation * Drug | 1.2787 | . 2595 | . 0064 | |
Contingency * Drug | 1.3819 | . 2412 | . 0069 | |
Contingency * Motivation * Drug | 0.1626 | . 6872 | . 0008 | |
Raw Peak Velocity | Motivation | 6.5921 | *.0110 | .0319 |
Contingency | 0.3831 | .5366 | .0019 | |
Drug | 1.8937 | .1703 | .0094 | |
Motivation * Contingency | 0.1179 | .7316 | .0006 | |
Motivation * Drug | 0.0563 | .8126 | .0003 | |
Contingency * Drug | 0.5462 | .4608 | .0027 | |
Contingency * Motivation * Drug | 2.4061 | .1224 | .0119 |
HC had a motivation*contingency interaction for endpoint variability, as only expected rewards decreased variability. **=p < 0.01.
Group | Effect | F (df = 1, 112) | p | |
---|---|---|---|---|
Peak Velocity Residuals | Motivation | 0.9019 | . 3443 | . 0080 |
Contingency | 0.3463 | . 5574 | . 0031 | |
Motivation * Contingency | 0.6995 | . 4047 | . 0062 | |
Amplitude | Motivation | 2.3510 | . 1280 | . 0206 |
Contingency | 0.0255 | . 8734 | . 0002 | |
Motivation * Contingency | 1.2551 | . 2650 | . 0111 | |
Saccade RT | Motivation | 3.2227 | . 0753 | . 0280 |
Contingency | 2.5743 | . 1114 | . 0225 | |
Motivation * Contingency | 2.7992 | . 0971 | . 0244 | |
Endpoint Variability | Motivation | 0.9304 | . 3368 | . 0082 |
Contingency | 0.6651 | . 4165 | . 0059 | |
Motivation * Contingency | 8.2781 | **.0048 | . 0688 | |
Raw Peak Velocity | Motivation | 1.1321 | .2896 | .0100 |
Contingency | 0.1615 | .6885 | .0014 | |
Motivation * Contingency | 0.2538 | .6154 | .0023 |
Effect | Estimate | t | p | |
---|---|---|---|---|
Peak Velocity Residuals | Motivation | 3.0488 | 1.922 | 0.0546 |
Contingency | 0.1392 | 0.0878 | 0.9301 | |
Drug | -0.0539 | -0.0339 | 0.9729 | |
Motivation * Contingency | 0.2380 | 0.1500 | 0.8808 | |
Motivation * Drug | 0.5420 | 0.3417 | 0.7326 | |
Contingency * Drug | 2.6239 | 1.6542 | 0.0981 | |
Contingency * Motivation * Drug | 3.5318 | 2.2266 | *0.0260 |
Statistics for main saccade measures.
Statistics for Pupil Dilatation.
Statistics for fixation period.
Correlations of questionnaires with motivational effects.